By extension, the differentiation treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid) [237] or acute myeloid leukemia with inhibitors of FMS-like tyrosine kinase 3 [238] reprograms gene expression. The gene discussed is FLT3; the disease is acute myeloid leukemia.